Todd B. Siwak
Known title: DirectorCIK: 0001929885
Associated companies
Transaction History
| MGPI | ▲ Buy | Grant | 5,801 | $0 | 5/14/2026 | View on chart |
| MGPI | ▲ Buy | Grant | 3,281 | $0 | 5/21/2025 | View on chart |
| MGPI | ▼ Sell | Open Market | 653 | $20K | 3/14/2025 | View on chart |
| MGPI | ▲ Buy | Grant | 476 | $19K | 1/2/2025 | View on chart |
| MGPI | ▼ Sell | Gift | 540 | $0 | 11/27/2024 | View on chart |
| MGPI | ▲ Buy | Grant | 224 | $19K | 10/3/2024 | View on chart |
| MGPI | ▲ Buy | Grant | 258 | $19K | 7/4/2024 | View on chart |
| MGPI | ▲ Buy | Grant | 1,183 | $0 | 5/24/2024 | View on chart |
| MGPI | ▲ Buy | Grant | 217 | $19K | 3/31/2024 | View on chart |
| MGPI | ▲ Buy | Grant | 198 | $19K | 1/4/2024 | View on chart |
| MGPI | ▲ Buy | Grant | 181 | $19K | 10/5/2023 | View on chart |
| MGPI | ▲ Buy | Grant | 164 | $17K | 7/6/2023 | View on chart |
| MGPI | ▲ Buy | Grant | 908 | $0 | 5/26/2023 | View on chart |
| MGPI | ▲ Buy | Grant | 181 | $17K | 4/6/2023 | View on chart |
| MGPI | ▲ Buy | Grant | 172 | $17K | 1/5/2023 | View on chart |
| MGPI | ▲ Buy | Grant | 160 | $17K | 10/6/2022 | View on chart |
| MGPI | ▲ Buy | Grant | 875 | $85K | 5/27/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
MGP Ingredients Cited as Potential Value Pick in Distillery Sector
A recent analysis highlights MGP Ingredients as a potentially undervalued option within the currently depressed distillery sector. The stock is trading near its 52-week low, with an RSI of 22.5 indicating oversold conditions. Analysts maintain an average price target of $27.80, which is significantly higher than the current support level of $17.57.
MGP Ingredients Cited as Potential Value Pick in Distillery Sector. A recent analysis highlights MGP Ingredients as a potentially undervalued option within the currently depressed distillery sector. The stock is trading near its 52-week low, with an RSI of 22.5 indicating oversold conditions. Analysts maintain an average price target of $27.80, which is significantly higher than the current support level of $17.57.